首页> 美国卫生研究院文献>Stem Cells International >Effect of Mesenchymal Stem Cells and Platelet-Rich Plasma on the Bone Healing of Ovariectomized Rats
【2h】

Effect of Mesenchymal Stem Cells and Platelet-Rich Plasma on the Bone Healing of Ovariectomized Rats

机译:间充质干细胞和富血小板血浆对去卵巢大鼠骨愈合的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We evaluated the efficacy of platelet-rich plasma (PRP) in combination with allogeneic bone marrow mesenchymal stem cells (BMSCs) for the treatment of osteoporotic bone defects in an ovariectomized rat model. By day 42 after injury, in vivo microcomputed tomography (micro-CT) imaging revealed that bone defects of control rats and ovariectomized rats treated with PRP and BMSCs were completely repaired, whereas those of ovariectomized rats treated with PRP or BMSCs alone exhibited slower healing. Histological data were consistent with these results. We also assessed changes to bone trabeculae in the proximal tibial growth plate. In ovariectomized rats treated with PRP or with a combination of PRP and BMSCs, the trabecular connectivity densities (Conn.D), bone volume ratios (BV/TV), and numbers (Tb.N) in the defect areas increased significantly from day 7 to day 42. These results indicate that PRP treatment enhances bone microarchitecture in osteoporosis. Moreover, expression levels of osteogenesis-specific marker genes including RUNX2, OSX, and OPN were significantly upregulated in rats treated with PRP and BMSCs compared to those of other groups. Thus, we conclude that treatment with PRP combined with BMSCs significantly promotes healing of osteoporotic bone defects. This study provides an alternative strategy for the treatment of osteoporotic bone loss.
机译:我们评估了富血小板血浆(PRP)与同种异体骨髓间充质干细胞(BMSC)结合在卵巢切除大鼠模型中治疗骨质疏松性骨缺损的功效。受伤后第42天,体内微计算机断层扫描(micro-CT)成像显示,对照组和经PRP和BMSC处理的去卵巢大鼠的骨缺损已完全修复,而仅经PRP或BMSC处理的去卵巢大鼠的骨缺损显示出较慢的愈合。组织学数据与这些结果一致。我们还评估了近端胫骨生长板中骨小梁的变化。从第7天开始,在接受PRP或PRP和BMSC组合治疗的去卵巢大鼠中,缺损区域的小梁连接密度(Conn.D),骨体积比(BV / TV)和数量(Tb.N)显着增加。到第42天。这些结果表明PRP治疗可增强骨质疏松症的骨微结构。此外,与其他组相比,在用PRP和BMSC治疗的大鼠中,成骨特异性标记基因(包括RUNX2,OSX和OPN)的表达水平显着上调。因此,我们得出结论,PRP与BMSC联合治疗可显着促进骨质疏松性骨缺损的愈合。这项研究为骨质疏松性骨丢失的治疗提供了另一种策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号